Project Grant R01DK146119
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Duke University $807,500 on August 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The project, titled "Decoding the Logic of Metabolite Pool Size Control," develops an integrated metabolic control discovery platform to understand the molecular mechanisms that regulate metabolite concentrations in cells. The research will systematically discover molecular...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The University of Chicago $123,000 on June 16, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to characterize adipocyte heterogeneity and response to metabolic stress. The funded research uses single-nucleus RNA sequencing and a humanized mouse model to investigate how diverse stimuli influence white adipocyte development and specification, with emphasis on...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded $1,634,996 to Boston University (Trustees of Boston University, doing business as Boston University Medical Campus) on February 18, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support research on vasculature and beige remodeling of obese adipose tissue. The research investigates how beige adipocyte recruitment and enhanced angiogenesis can counteract unhealthy...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Leland Stanford Junior University $782,886 on February 18, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support research on obesity control through an appetite-suppressing peptide. The research addresses the urgent need for new metabolies, including obesity and associated metabolic disorders. Work is performed in Palo Alto, California with a period of...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of California, Los Angeles $167,363 on March 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support basic and clinical biomedical research on novel central nervous system mechanisms in obesity. The award funds research investigating how the paraventricular nucleus of the hypothalamus integrates nutrient-related cues to control peripheral energy and...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Yale University $839,770 on June 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support cognitive and behavioral approaches to reduce binge eating and excess weight in adolescents. The award is a Project Grant with a period of performance extending through February 28, 2031, and work is performed in New Haven, Connecticut. The program promotes extramural basic...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Washington $888,773 on April 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847, Project Grant R01DK140210). The award funds research defining the contributions of hypothalamic microglia and perineuronal nets to obesity pathogenesis. The project investigates inflammatory activation of hypothalamic microglia in the arcuate nucleus and the loss of...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Cincinnati Children's Hospital Medical Center $771,701 on June 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to delineate the impact of beige adipocytes in whole-body energy metabolism. The funded research addresses a gap in understanding adipose tissue biology by investigating the role of beige adipocytes in energy expenditure and metabolic health. Using a novel...
- The National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health under the Department of Health and Human Services, awarded $717,030 to the University of Virginia on May 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to uncover neural circuits controlling body weight and metabolism. The research develops and applies RAMPANT (rabies afferent mapping by poly-A nuclear transcriptomics), a novel...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of New Mexico Health Sciences Center $755,124 on May 20, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to characterize bone marrow adiponectin signaling and its role in immune regulation. The research investigates how adiponectin, the most abundant adipose-derived hormone, regulates hematopoiesis and B cell development within the bone marrow...
The National Institute of Diabetes and Digestive and Kidney Diseases awarded Duke University $790,119 on August 26, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate how memory formation in adipose tissue influences metabolic outcomes in obesity. The project, titled "Establishing Memory in Adipose Tissue Influences Future Metabolic Outcomes in Obesity," examines the mechanisms that drive divergent remodeling of white adipose tissue during obesity, with particular focus on adaptive versus maladaptive tissue remodeling and their influence on weight-loss therapy response. The research builds on preliminary findings showing that short-term pharmacological or physiological stimulation induces adaptive remodeling that leaves behind a persistent pool of metabolically flexible adipocytes. When challenged later with a high-fat diet, mice with these "trained" adipocytes remain protected from maladaptive visceral adipose tissue remodeling and insulin resistance. The project aims to leverage these legacy effects as an experimental tool to define the physiological benefits and molecular determinants of healthy adipose remodeling in obesity. Work is performed in Durham, North Carolina, with a period of performance from the award date through June 30, 2030. This is a project grant assistance type supporting basic and clinical biomedical research to improve understanding of disease mechanisms and advance prevention, diagnosis, and treatment of diabetes, digestive, and kidney diseases.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $790.1k | 8/27/26 |